$2.01
+0.75%Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.
Last Annual Value
1.51M
3-Year CAGR
%
5-Year CAGR
%
10-Year CAGR
%
| Company | Interest Expense | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
![]() Spectral AI, Inc. NASDAQ:MDAI | 1.51M | N/A | N/A | N/A | |
![]() Coeptis Therapeutics, Inc. NASDAQ:COEP | 642.38K | 81.4% | 28.0% | N/A | |
![]() Century Therapeutics, Inc. NASDAQ:IPSC | 0.00 | N/A | N/A | N/A | |
![]() Sensus Healthcare, Inc. NASDAQ:SRTS | 0.00 | N/A | N/A | N/A | |
![]() Equillium, Inc. NASDAQ:EQ | 0.00 | N/A | N/A | N/A | |
![]() CAMP4 Therapeutics Corporation NASDAQ:CAMP | 0.00 | N/A | N/A | N/A | |
![]() Gain Therapeutics, Inc. NASDAQ:GANX | 0.00 | N/A | N/A | N/A | |
![]() Pulmonx Corporation NASDAQ:LUNG | 3.15M | -0.8% | 30.6% | N/A | |
![]() Vivani Medical, Inc. NASDAQ:VANI | 0.00 | N/A | N/A | N/A | |
![]() Karyopharm Therapeutics Inc. NASDAQ:KPTI | 45.85M | 24.4% | 12.0% | N/A | |
![]() TELA Bio, Inc. NASDAQ:TELA | 5.25M | 0.1% | 7.8% | N/A |
Continue your MDAI research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.